123 related articles for article (PubMed ID: 1281831)
21. Coagulation factor V: an old star shines again.
Rosing J; Tans G
Thromb Haemost; 1997 Jul; 78(1):427-33. PubMed ID: 9198191
[TBL] [Abstract][Full Text] [Related]
22. Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis.
Kim SW; Quinn-Allen MA; Camp JT; Macedo-Ribeiro S; Fuentes-Prior P; Bode W; Kane WH
Biochemistry; 2000 Feb; 39(8):1951-8. PubMed ID: 10684644
[TBL] [Abstract][Full Text] [Related]
23. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
Krishnaswamy S; Walker RK
Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
[TBL] [Abstract][Full Text] [Related]
24. The factor V C1 domain is involved in membrane binding: identification of functionally important amino acid residues within the C1 domain of factor V using alanine scanning mutagenesis.
Saleh M; Peng W; Quinn-Allen MA; Macedo-Ribeiro S; Fuentes-Prior P; Bode W; Kane WH
Thromb Haemost; 2004 Jan; 91(1):16-27. PubMed ID: 14691564
[TBL] [Abstract][Full Text] [Related]
25. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of a phospholipid-binding site of bovine factor Va.
Kalafatis M; Jenny RJ; Mann KG
J Biol Chem; 1990 Dec; 265(35):21580-9. PubMed ID: 2254316
[TBL] [Abstract][Full Text] [Related]
27. Functional properties of recombinant factor V mutated in a potential calcium-binding site.
Sørensen KW; Nicolaes GA; Villoutreix BO; Yamazaki T; Tans G; Rosing J; Dahlbäck B
Biochemistry; 2004 May; 43(19):5803-10. PubMed ID: 15134454
[TBL] [Abstract][Full Text] [Related]
28. Strenuous exercise promotes shear-induced thrombin generation by increasing the shedding of procoagulant microparticles from platelets.
Chen YW; Chen JK; Wang JS
Thromb Haemost; 2010 Aug; 104(2):293-301. PubMed ID: 20589321
[TBL] [Abstract][Full Text] [Related]
29. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding.
Ajzner E; Balogh I; Haramura G; Boda Z; Kalmár K; Pfliegler G; Dahlbäck B; Muszbek L
J Thromb Haemost; 2003 May; 1(5):943-9. PubMed ID: 12871359
[TBL] [Abstract][Full Text] [Related]
30. Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex.
Peng W; Quinn-Allen MA; Kim SW; Alexander KA; Kane WH
Biochemistry; 2004 Apr; 43(14):4385-93. PubMed ID: 15065883
[TBL] [Abstract][Full Text] [Related]
31. Completed three-dimensional model of human coagulation factor va. Molecular dynamics simulations and structural analyses.
Orban T; Kalafatis M; Gogonea V
Biochemistry; 2005 Oct; 44(39):13082-90. PubMed ID: 16185076
[TBL] [Abstract][Full Text] [Related]
32. Factor Xa dimerization competes with prothrombinase complex formation on platelet-like membrane surfaces.
Koklic T; Chattopadhyay R; Majumder R; Lentz BR
Biochem J; 2015 Apr; 467(1):37-46. PubMed ID: 25572019
[TBL] [Abstract][Full Text] [Related]
33. Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor Va.
Srivastava A; Quinn-Allen MA; Kim SW; Kane WH; Lentz BR
Biochemistry; 2001 Jul; 40(28):8246-55. PubMed ID: 11444970
[TBL] [Abstract][Full Text] [Related]
34. Activation/inactivation of human factor V by plasmin.
Lee CD; Mann KG
Blood; 1989 Jan; 73(1):185-90. PubMed ID: 2521293
[TBL] [Abstract][Full Text] [Related]
35. Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases.
Dharmawardana KR; Bock PE
Biochemistry; 1998 Sep; 37(38):13143-52. PubMed ID: 9748321
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations.
Kalafatis M; Simioni P; Tormene D; Beck DO; Luni S; Girolami A
Blood; 2002 Jun; 99(11):3985-92. PubMed ID: 12010798
[TBL] [Abstract][Full Text] [Related]
37. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT.
Connor DE; Exner T; Ma DD; Joseph JE
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):558-64. PubMed ID: 19593114
[TBL] [Abstract][Full Text] [Related]
38. Leishmania amazonensis exhibits phosphatidylserine-dependent procoagulant activity, a process that is counteracted by sandfly saliva.
Rochael NC; Lima LG; Oliveira SM; Barcinski MA; Saraiva EM; Monteiro RQ; Pinto-da-Silva LH
Mem Inst Oswaldo Cruz; 2013 Sep; 108(6):679-85. PubMed ID: 24037188
[TBL] [Abstract][Full Text] [Related]
39. Crystal structures of the membrane-binding C2 domain of human coagulation factor V.
Macedo-Ribeiro S; Bode W; Huber R; Quinn-Allen MA; Kim SW; Ortel TL; Bourenkov GP; Bartunik HD; Stubbs MT; Kane WH; Fuentes-Prior P
Nature; 1999 Nov; 402(6760):434-9. PubMed ID: 10586886
[TBL] [Abstract][Full Text] [Related]
40. Cross-reactivity of rabbit anti-bovine prothrombin/thrombin IgGs with bovine factor V/Va-related antigens.
He Zhu ; Hoppensteadt D; Morris M; Fareed J
Clin Appl Thromb Hemost; 2010 Oct; 16(5):522-8. PubMed ID: 20699260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
